Patent Term Extensions Masterclass

19 October, 2022
7:45am – 3:45pm

Join leading SPC authorities as they address crucial milestones for the application and enforcement of patent term extensions in Europe and throughout the world.

Add the Masterclass to your registration or have a colleague attend. Savings is available for an organization that registers within one transaction for both events!

Learn more

Judge Edger F. Brinkman

Senior Judge Civil Law Division – IP
Court of The Hague, The Netherlands


Professor Willem Hoyng

Chairman, Advisory Committee of the UPC
Member, Drafting Committee of the Rules of Proceedings of the UPC

Key Industry Leaders

Sarah Burghart

Lead IP Litigation Counsel


Dr. Holger Dulat

VP, Intellectual Property


Guido Pontremoli, Ph.D.

Global IP Head
Chiesi Farmaceutici S.p.A.


Dr. Corinna Sundermann

Senior Vice President, Intellectual Property Management, Business Center COO
Fresenius Kabi


Maria Nichol

Head of IP
Agomab Therapeutics

2022 Co-Chairs

Gregory Bacon

Bristows LLP


Dr. Andreas von Falck

Hogan Lovells

Be part of Europe’s leading Life Sciences IP Think Tank at the dawn of the New Unitary Patent Era.

It is a new dawn for European patents. The creation of a new Unified Patent Court and a new patent with unitary effect will fundamentally change the international patent prosecution and litigation landscape for years to come. C5 is thrilled to welcome you back to Munich for the 20th anniversary of Europe’s original Life Sciences IP Summit at a time when the industry is on the precipice of such significant change.

Also, a new one-day add-on for this year is the Patent Term Extensions Masterclass, which will be focused on SPCs and patent extension developments in Europe and around the world.

New for 2022

As Europe enters and exciting new era in IP, we are pleased to offer a:

  • Spotlight on Patent Prosecution Tools for the New Unitary Patent Era
  • Strategy Session for Patent Litigation in the Unified Patent Court

Additional Program Highlights, include:

  • Focus Session on Plausibility, Sufficiency, and Inventive Step: Considerations for Formulation, Combination and Second Medical Use Patents
  • Tactical Tool-Kit for Claiming Antibody and Epitope Claims
  • Update on Priority: Incorporating the Latest Jurisprudence Into Your Patent Prosecution Strategy
  • Life Sciences Litigator Think Tank: “What I Wish the Patent Prosecutor Would Have Done”
Quote Icon

Another great C5 conference. Good variety of attendees and topics.

Robin Ellis, Head of IP Product, Sandoz
Quote Icon

Good meeting; I enjoyed it a lot, including both the talks and the social side.

Andrew Bentham, Patent Attorney, JA Kemp
Quote Icon

Again, very good speakers from all over Europe and the US.

Chrisoph Rehfuss, Head of IP, Sotio
  • Ablynx NV
  • Alkermes Pharma Ireland Ltd
  • AstraZeneca AB
  • Benitec Biopharma Limited
  • Biotronik
  • Boehringer Ingelheim
  • Celltrion
  • Chiesi Farmaceutici Spa
  • EGIS Pharmaceuticals PLC
  • Esteve Group
  • European Patent Office
  • F. Hoffmann-La Roche Ltd
  • Federal Agency for Nature
  • Finnish Patent and Registration Office
  • Fresenius Medical Care AG & Co
  • Fresenius Medical Care AG & Co. KG Aa
  • Geistlich Pharma AG
  • Genmab AS
  • German Patent & Trade Mark Office
  • GlaxoSmithKline
  • Groupe Sanofi
  • Helsinn Healthcare SA
  • JETRO Duesseldorf
  • Leukocare AG
  • Linde Healthcare
  • Merus NV
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • PARI Pharma GmbH
  • Patent Office Denmark
  • Patents Office Ireland
  • Sandoz International GmbH
  • Sanofi-Aventis Deutschland GmbH
  • Silence Therapeutics Plc
  • Swiss Federal Institute of Intellectual Property
  • Teva Pharmaceuticals Ltd
  • TiGenix NV
  • UCB Chong Kun Dang pharm.
  • Valea AB
  • Zacco Denmark AS
  • Zealand Pharma AS
  • Zentiva Group
Past Attendees by Country
Representatives from corporate organisations from functions including:
  • Patent Counsel
  • Head of IP
  • VP-Intellectual Property
  • Scientific Director
  • Senior IP Counsel
  • Associate General Counsel IP
  • European Patent Attorney
  • Head of Legal Affairs
  • Principal Patent Examiner
  • Vice President & Chief Counsel – IP
  • VP Head Group Intellectual Property
  • Head of Global Strategy
  • Direct of Patent and Design Rights
  • CTO
  • Product Manager
  • Director Innovation, IP and Portfolio Management
  • Director IP Strategy & Projects
  • R&D Patent Manager
  • Technology Development Manager
  • Associate VP & Director of Technology Licensing & Commercialization
Legal Practitioners
  • Intellectual Property and Patent
  • Life Sciences
  • European Patent
  • US Patent
Related Conferences
Event Thumbnail Image
Event Thumbnail Image